Again the group of Prof. Harald Schmidt (Dept. of Pharmacology) was successful in obtaining external funding for their research. Dr Kim Radermacher was granted a personal grant by the Netherlands Brain Foundation. Schmidt obtained an EU COST-grant.


Last week, post-doc Kim Radermacher obtained a Fellowship for her research project entitled ‘Inhibition of NADPH oxidases as a new mechanistic approach to promote recovery in stroke: Validation by non-invasive brain redox imaging’. The Netherlands Brain Foundation wants to prevent and heal brain disorders. For the Fellowship subsidy (150 K€), the Foundation works with research programs linked to priority areas. For more information please visit the website (only in Dutch).  

Furthermore the EU-ROS proposal has been approved by the European Cooperation in Science and Technology (COST) on June 7. COST is an intergovernmental framework, allowing the coordination of nationally-funded reearch on a European level. The mission and goal of COST is to contribute to reducing the fragmentation in European research investments and opening the European Research Area (ERA) to cooperation worldwide.

back